GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is one of the most thoroughly researched naturally occurring peptides in anti-aging biology. First isolated from human plasma in 1973 by Loren Pickart, it has since accumulated a remarkable body of scientific literature spanning dermatology, wound healing, neuroscience, and genomics.

The peptide's natural role involves wound signalling — plasma concentrations of GHK rise sharply after tissue injury, recruiting repair processes. As a copper chelator, GHK-Cu facilitates copper delivery to enzymes critical for collagen and elastin synthesis, including lysyl oxidase, which cross-links these structural proteins to maintain tissue integrity.

Skin biology research has produced some of the most compelling GHK-Cu data. Studies have documented increased collagen I, III, and IV synthesis in fibroblast cultures, enhanced metalloproteinase (MMP) activity for remodelling damaged extracellular matrix, and improved expression of integrins that anchor cells to collagen scaffolds. The net result observed in preclinical models is a younger structural profile in treated tissues.

One of the more striking findings comes from genomics research. A 2014 study analysed the effect of GHK-Cu on a broad gene panel and found it modulated over 4,000 human genes, with a pattern resembling the reversal of disease-associated gene expression changes. Genes associated with inflammation, DNA damage, and cancer progression were downregulated, while those involved in cellular repair and metabolism were upregulated.

Antioxidant research has confirmed GHK-Cu's ability to scavenge reactive oxygen species and upregulate antioxidant enzymes including superoxide dismutase and catalase. This activity may contribute to its documented reduction of oxidative damage markers in cell culture studies.

Neurological research is an emerging area. GHK-Cu has shown neuroprotective properties in models of cognitive decline, with some studies suggesting it may support BDNF (brain-derived neurotrophic factor) expression and protect against heavy metal neurotoxicity — both areas of active investigation.

Wound healing applications have been extensively studied. GHK-Cu promotes angiogenesis (new blood vessel formation), accelerates re-epithelialization, and reduces the formation of hypertrophic scars in animal models. The peptide's ability to simultaneously recruit repair cells and modulate inflammatory responses makes it especially interesting for complex wound protocols.

Analytical verification for GHK-Cu requires confirming both the peptide sequence (Gly-His-Lys) and the copper chelation ratio. Mass spectrometry is essential for sequence confirmation. HPLC should show purity above 98%, with copper content analysed separately. Improperly chelated or degraded product will not reproduce literature results.

Storage is straightforward: lyophilized GHK-Cu powder is stable at room temperature for short periods but is best kept at -20°C for long-term storage. Aqueous solutions should be refrigerated and used promptly.

GHK-Cu represents an unusually well-characterised naturally occurring peptide — one of the few with meaningful mechanistic data at the gene expression level. Researchers working in anti-aging, dermatology, or tissue repair will find a rich literature base and a compound whose mechanism is increasingly well understood.